drug

mesalamine PR

Marketedupdated 3mo ago

by Takeda Pharmaceuticals USA Inc

Approved

community read0 votes

🐶 often sniffed alongside

top 2

all catalysts(0)

nothing on the calendar yet

Trials studying mesalamine PR

phase3A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitiswithdrawn
phase1Mesalamine 4 gm/60 mL Rectal Enemacompletedn=72
phase2Mesalazine Oral Suspension in Active Eosinophilic Esophagitiscompletedn=5

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 47m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

mesalamine PR

Marketedupdated 3mo ago

by Takeda Pharmaceuticals USA Inc

Approved

community read0 votes

🐶 often sniffed alongside

top 2

all catalysts(0)

nothing on the calendar yet

Trials studying mesalamine PR

phase3A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitiswithdrawn
phase1Mesalamine 4 gm/60 mL Rectal Enemacompletedn=72
phase2Mesalazine Oral Suspension in Active Eosinophilic Esophagitiscompletedn=5

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 47m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

mesalamine PR

🐶 often sniffed alongside

all catalysts(0)

Trials studying mesalamine PR

News(0)

Report a data issue

comments(0)

mesalamine PR

🐶 often sniffed alongside

all catalysts(0)

Trials studying mesalamine PR

News(0)

Report a data issue

comments(0)